These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 4048236)
1. Low doses of methylnaloxonium in the nucleus accumbens antagonize hyperactivity induced by heroin in the rat. Amalric M; Koob GF Pharmacol Biochem Behav; 1985 Sep; 23(3):411-5. PubMed ID: 4048236 [TBL] [Abstract][Full Text] [Related]
2. Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat. Vaccarino FJ; Bloom FE; Koob GF Psychopharmacology (Berl); 1985; 86(1-2):37-42. PubMed ID: 2991967 [TBL] [Abstract][Full Text] [Related]
3. Effects of opiate antagonist treatment into either the periaqueductal grey or nucleus accumbens on heroin-induced locomotor activation. Vaccarino FJ; Corrigall WA Brain Res Bull; 1987 Nov; 19(5):545-9. PubMed ID: 3690365 [TBL] [Abstract][Full Text] [Related]
4. Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal. Koob GF; Wall TL; Bloom FE Psychopharmacology (Berl); 1989; 98(4):530-4. PubMed ID: 2505294 [TBL] [Abstract][Full Text] [Related]
5. Hyperactivity induced by N-methyl-d-aspartate injections into nucleus accumbens: lack of evidence for mediation by dopaminergic neurons. O'Neill KA; Carelli RM; Jarvis MF; Liebman JM Pharmacol Biochem Behav; 1989 Dec; 34(4):739-45. PubMed ID: 2560212 [TBL] [Abstract][Full Text] [Related]
6. Nucleus accumbens opiate-dopamine interactions and locomotor activation in the rat: evidence for a pre-synaptic locus. Swerdlow NR; Amalric M; Koob GF Pharmacol Biochem Behav; 1987 Apr; 26(4):765-9. PubMed ID: 3110795 [TBL] [Abstract][Full Text] [Related]
7. A comparison of the effects of intra-accumbens injections of amphetamine and morphine on reinstatement of heroin intravenous self-administration behavior. Stewart J; Vezina P Brain Res; 1988 Aug; 457(2):287-94. PubMed ID: 3219557 [TBL] [Abstract][Full Text] [Related]
8. Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing. Kalivas PW; Nemeroff CB; Prange AJ Neuroscience; 1984 Apr; 11(4):919-30. PubMed ID: 6738859 [TBL] [Abstract][Full Text] [Related]
9. Effect of a novel environment on locomotor hyperactivity of rats induced by apomorphine in the nucleus accumbens. Morgenstern R; Fink H Biomed Biochim Acta; 1985; 44(10):1517-22. PubMed ID: 4084255 [TBL] [Abstract][Full Text] [Related]
10. Microinjections of an opiate receptor antagonist into the bed nucleus of the stria terminalis suppress heroin self-administration in dependent rats. Walker JR; Ahmed SH; Gracy KN; Koob GF Brain Res; 2000 Jan; 854(1-2):85-92. PubMed ID: 10784110 [TBL] [Abstract][Full Text] [Related]
11. Electrophysiological analysis of the neural circuitry underlying opiate effects in the nucleus accumbens septi. Hakan RL; Callaway C; Henriksen SJ Neurosci Lett; 1989 Jun; 101(2):163-8. PubMed ID: 2771162 [TBL] [Abstract][Full Text] [Related]
12. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Stinus L; Le Moal M; Koob GF Neuroscience; 1990; 37(3):767-73. PubMed ID: 2247222 [TBL] [Abstract][Full Text] [Related]
13. Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens. Vezina P; Kalivas PW; Stewart J Brain Res; 1987 Aug; 417(1):51-8. PubMed ID: 3040185 [TBL] [Abstract][Full Text] [Related]
14. Increased food intake after opioid microinjections into nucleus accumbens and ventral tegmental area of rat. Mucha RF; Iversen SD Brain Res; 1986 Nov; 397(2):214-24. PubMed ID: 3026557 [TBL] [Abstract][Full Text] [Related]
15. Increased mesolimbic GABA concentration blocks heroin self-administration in the rat. Xi ZX; Stein EA J Pharmacol Exp Ther; 2000 Aug; 294(2):613-9. PubMed ID: 10900239 [TBL] [Abstract][Full Text] [Related]
17. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
18. A comparison of the behavioural consequences of chronic stimulation of dopamine receptors in the nucleus accumbens of rat brain effected by a continuous infusion or by single daily injections. Costall B; Domeney AM; Naylor RJ Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):27-33. PubMed ID: 6633677 [TBL] [Abstract][Full Text] [Related]
19. Effects of 5-HT3 receptor-selective agents on locomotor activity in rats following injection into the nucleus accumbens and the ventral tegmental area. Gillies DM; Mylecharane EJ; Jackson DM Eur J Pharmacol; 1996 May; 303(1-2):1-12. PubMed ID: 8804905 [TBL] [Abstract][Full Text] [Related]
20. The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat. Hamilton M; Sheehan MJ; De Belleroche J; Herberg LJ Neurosci Lett; 1984 Jan; 44(1):77-82. PubMed ID: 6717857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]